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Omid Mehrpour1,2*Sir,
I read with great interest the recent article published by
Sadeghi et al., "Report of methamphetamine use and car-
diomyopathy in three patients" [1].
The authors state that" cardiomyopathy and acute heart
failure may be a new medical concern". Methampheta-
mine induced cardiomyopathy is certainly a medical con-
cern, and while it is not often reported in Iran, it is a well
described clinical finding in the medical literature.
Wijetunga et al. retrospectively reviewed 21 crystal meth-
amphetamine hospitalized cases and found that 84% of
patients had dilated cardiomyopathy and global ventricu-
lar dysfunction in echocardiography. They also concluded
that the pathogenesis is probably similar to that of cocaine
and catecholamine-induced cardiomyopathy [2].
Moreover, Yeo et al. in a study on 107 cases of cardiomy-
opathy found that methamphetamine users had a 3.7-fold
increased odds ratio for cardiomyopathy, adjusting for age,
body mass index, and renal failure. In their retrospective
study, 40% of patients under the age of 40 with cardiomy-
opathy had a history of recent methamphetamine abuse [3].
In addition, as the authors have mentioned, the use of
methamphetamine has grown significantly in Iran over
the past few years. Complicating the monitoring of drug
abuse trends is the street names of illicit drugs are
unique to Iran. For exam, Iranian crystal is marketed to
Iranian youngsters and the main ingredient is heroin. In
central and western Iran, methamphetamine may also be
added to this opiate-based drug. Some Iranian addicts
(and perhaps researchers) believe that the crystal is actu-
ally crystal-meth (amphetamine base) because of the
similarity in names [4].
Shishe is another common street drug name in Iran
and the main ingredient is methamphetamine.
Iran has the highest rate of opioid drugs addicts in the
world [4-6] and with Iranian crystal exposure to meth-
amphetamine may be increasing. Crystal meth and
Shishe are also now widely abused.Correspondence: omid.mehrpour@yahoo.com.au
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reproduction in any medium, provided the orWith the increasing use of methamphetamine, both
knowingly (in the cases of crystal-meth and Shishe) and
unknowingly (in the case of Iranian Crystal), it is likely
that we will see more cases of drug induced cardiomyop-
athy in the country.
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